首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Critical Reviews In Immunology

Critical Reviews In Immunology杂志,由Begell House Inc.出版,于1980年创刊,Bimonthly,出版语言English,ISSN:1040-8401,E-ISSN:2162-6472。

投稿咨询
Critical Reviews In Immunology
Critical Reviews In Immunology
Critical Reviews In Immunology
SCI SCIE

杂志介绍

JCR分区
Q4
中科院分区
4区
影响因子
1.8
CiteScore
2.2
期刊收录
SCI、SCIE

Critical Reviews In Immunology(中文译名:《免疫学评论》),ISSN:1040-8401,EISSN:2162-6472,是Begell House Inc.出版的国际性学术期刊,创刊于1980年,以Bimonthly形式稳定发行,2026年总发文量约30篇。该刊采用非OA开放访问,学科归属为医学 - 免疫学。该刊是医学、免疫学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达1.8,2025年期刊CiteScore为2.2,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Critical Reviews In Immunology长期聚焦医学、免疫学及相关产业的技术应用前沿,平均审稿周期>12周,或约稿,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、免疫学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、India、Brazil、France、GERMANY (FED REP GER)、Japan等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMUNIVERSIDADE DE SAO PAULO、DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA、EMORY UNIVERSITY、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、UNIVERSITY OF PENNSYLVANIA、BANARAS HINDU UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
IMMUNOLOGY 免疫学
4区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
IMMUNOLOGY 免疫学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
IMMUNOLOGY 免疫学
4区
否 是

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q4 153 / 183

16.7

学科:IMMUNOLOGY SCIE Q4 151 / 183

17.76

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q4 172 / 183

6.3

学科:IMMUNOLOGY SCIE Q4 175 / 183

4.64


中国学者近期发文

1
Knockdown of IGF2BP2 Inhibits THBS1 in Regulating the Progression of Oral Squamous Cell Carcinoma: An Integrative Analysi

Author:He, Ying; Wang, Wei

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2026; Vol. 46, Issue 2, pp. 45-58. DOI:

2
Secreted Phosphoprotein 1 Represents a Therapeutic Target that Promotes the Progression of Ovarian Cancer by Driving M2 Macrophage Infiltratio

Author:Yang, Xiaorong; Zhu, Hong; Zou, Xia; Chen, Qi

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2026; Vol. 46, Issue 2, pp. 1-14. DOI: 10.1615/CritRevImmunol.2026061544

3
Fusion Gene EPHB4-MET Driven by HOXA9 and Exerted Oncogenic Activity in Non-Small Cell Lung Cance

Author:Xia, Wenjia; Zhu, Wenjing; Feng, Dongjie; Xu, Youtao; Liu, Tongyan; Xu, Lin

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2026; Vol. 46, Issue 2, pp. -. DOI:

4
Combined Ursolic Acid and Rosuvastatin Treatment Mitigates Inflammation and Oxidative Stress in Diabetic Nephropathy Model Cell

Author:Zhou, Yijing; Lou, Chengli; Wang, Xiangjing; Hu, Pingxin; Xu, Xiuqin

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2026; Vol. 46, Issue 1, pp. 59-72. DOI:

5
The Combined Administration of Disulfiram and Baicalin Alleviates Membranous Nephropathy by Inhibiting Podocyte Inflammation and Pyroptosi

Author:Lou, Chengli; Zhou, Yijing; Feng, Bo; Fan, Xiaoping; Xu, Xiuqin; Hu, Pingxin; Wang, Xiangjing

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2026; Vol. 46, Issue 1, pp. 73-84. DOI:

6
Construction of an Immunogenic Cell Death-Related Long Non-Coding RNA Signature for Predicting Prognosis in Osteosarcom

Author:Luo, Huihuang

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2026; Vol. 46, Issue 1, pp. -. DOI:

7
Single-Cell Sequencing Combined with RNA Sequencing Reveals the Role of Natural Killer Cells in Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinom

Author:Lin, Jiemin; Lin, Meichun; Lin, Lianxing; Chen, Qiaojun; Yao, Erhua; Lu, Jiayang

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2026; Vol. 46, Issue 1, pp. -. DOI:

8
Assessing the Relationship among Tumor Size, Lymph Node Status, and ER/PR/HER2 Expression in Patients with Breast Cance

Author:Wu, Liqin; Zhou, Xianghua; Yang, Fanfan

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2025; Vol. 45, Issue 3, pp. -. DOI:

9
Pathogenesis, Diagnosis, Treatment, and Prognosis of CD20-Positive T and NK Cell Lymphoma: A Revie

Author:Liu, Yang; Li, Bo; Chen, Xiaomin; Xiong, Hao; Huang, Chunlan

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2025; Vol. 45, Issue 3, pp. 11-18. DOI:

10
Dual Inhibition of IRE1α and YAP Signaling as a Potential Therapy for Epithelial Ovarian Carcinom

Author:Liu, Fei; Tu, Chunhua; Tan, Buzhen; He, Linsheng; Wen, Yuan

Journal: CRITICAL REVIEWS IN IMMUNOLOGY. 2025; Vol. 45, Issue 3, pp. 19-32. DOI:


在线咨询

Critical Reviews In Immunology

国际简称:CRIT REV IMMUNOL参考译名:免疫学评论

年发文量:30 CiteScore:2.2 是否预警:否 Gold OA文章占比:2.83% 研究类文章占比:93.33%

杂志社联系方式:BEGELL HOUSE INC, 50 CROSS HIGHWAY, REDDING, USA, CT, 06896

Critical Reviews In Immunology